Creon may refer to:

Greek history
Creon, the first annual eponymous archon of Athens, 682–681 BC

Greek mythology
Creon (king of Thebes), mythological king of Thebes
Creon (king of Corinth), father of Creusa/Glauce in Euripides Medea
Creon, son of Heracles by a daughter of Thespius, king of Thespiae

Medicine
Creon, a brand name of a pancreatic enzymes medication

Places
Créon, a commune in the Gironde department in France
Créon-dArmagnac, a commune in the Landes department in France

Other
Creon a genus of butterfly, in the family Lycaenidae, containing the species Broadtail royal
USS Creon (ARL-11), a World War II U.S. Navy landing craft repair ship

See also
Kreon, a DC Comics character
Kreon, a minifigure (similar to Lego minifigure) from Kre-O construction toys manufactured by Oxford, a Korean company, and marketed by Hasbro
Adults
In 2001 the American Thoracic Society, drawing on the work of the British and Canadian Thoracic Societies, established guidelines for the management of adult CAP by dividing patients into four categories based on common organisms:
Healthy outpatients without risk factors: This group (the largest) is composed of otherwise-healthy patients without risk factors for DRSP, enteric gram-negative bacteria, pseudomonas or other, less common, causes of CAP. Primary microorganisms are viruses, atypical bacteria, penicillin-sensitive streptococcus pneumoniae and haemophilus influenzae. Recommended drugs are macrolide antibiotics, such as azithromycin or clarithromycin, for seven to ten days. A shorter course of these antibiotics has been investigated, however, there is not sufficient evidence to make recommendations. Outpatients with underlying illness or risk factors: Although this group does not require hospitalization, they have underlying health problems such as emphysema or heart failure or are at risk for DRSP or enteric gram-negative bacteria. They may be treated with a quinolone active against streptococcus pneumoniae (such as levofloxacin) or a β-lactam antibiotic (such as cefpodoxime, cefuroxime, amoxicillin or amoxicillin/clavulanic acid) and a macrolide antibiotic, such as azithromycin or clarithromycin, for seven to ten days. Hospitalized patients without risk for pseudomonas: This group requires intravenous antibiotics, with a quinolone active against streptococcus pneumoniae (such as levofloxacin), a β-lactam antibiotic (such as cefotaxime, ceftriaxone, ampicillin/sulbactam or high-dose ampicillin plus a macrolide antibiotic (such as azithromycin or clarithromycin) for seven to ten days. Intensive-care patients at risk for pseudomonas aeruginosa: These patients require antibiotics targeting this difficult-to-eradicate bacterium.